share_log

Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(0%),Janus Henderson Biotech Innovation Master Fund Ltd(0%)

SEC announcement ·  Jun 9, 2023 13:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more